LINEAGE CELL THERAPEUTICS IN
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for LINEAGE CELL THERAPEUTICS IN PUT, CUSIP 53566P959.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for LINEAGE CELL THERAPEUTICS IN PUT, CUSIP 53566P959.